This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Jan 4;143(1):5-7.

doi: 10.1182/blood.2023022243.

Ibrutinib reversal of immune exhaustion in CLL

Paul Moss¹

Affiliations

PMID: 38175677
DOI: 10.1182/blood.2023022243

Free article

Editorial

Ibrutinib reversal of immune exhaustion in CLL

Paul Moss. Blood. 2024.

Free article

. 2024 Jan 4;143(1):5-7.

doi: 10.1182/blood.2023022243.

Author

Paul Moss¹

Affiliation

¹ University of Birmingham.

PMID: 38175677
DOI: 10.1182/blood.2023022243

No abstract available

PubMed Disclaimer

Comment on

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.
Papazoglou D, Wang XV, Shanafelt TD, Lesnick CE, Ioannou N, De Rossi G, Herter S, Bacac M, Klein C, Tallman MS, Kay NE, Ramsay AG. Papazoglou D, et al. Blood. 2024 Jan 4;143(1):57-63. doi: 10.1182/blood.2023020554. Blood. 2024. PMID: 37824808 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems